Project Grant R01NS141988
Award Date
5/6/25
Completion Date
2/28/30
Dollars Obligated
$631K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Charlestown, MA 02129, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), totaling $619,470. The award period runs from September 1, 2024 to July 31, 2029. The grant supports research to map the neural activity signatures associated with tumor infiltration in the human brain. MGH will utilize...
This Project Grant award, valued at $404,100.00, was issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award will support research by The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to investigate the mechanisms of chronic blood-brain barrier dysfunction after traumatic brain injury (TBI). The...
The federal Project Grant award R37NS136068, titled "The Skull Bone Marrow Niche After Stroke," is funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $798,848 award to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), will support research investigating how the skull bone marrow niche, which is directly...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $397,500 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program to the Massachusetts Institute of Technology (MIT). The grant, effective May 1, 2025 through April 30, 2030, will support innovative research to study fundamental principles linking neurodevelopmental processes to the functional organization of neural circuits. The goal is to...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will fund research to investigate the role of red blood cells in stroke-related hyperglycemia. The total award amount is $1,267,716.00 for the project period from August 1, 2024 to May 31, 2029. The primary awardee is The General...
This $454,225 Project Grant award from the National Institute on Aging's Aging Research federal grant program (CFDA 93.866) will support research at The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop new methods for assessing "effective reserve" in patients with acute ischemic stroke. The key objectives are to: 1) investigate the concept of effective reserve and its feasibility in acute ischemic stroke patients using two large...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $652,497 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct a research study on stroke-induced proximal upper extremity motor control impairment and rehabilitation. The key objectives of this 5-year project are to: (1)...
This federal Project Grant award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate how deficiencies in the red blood cell enzyme bisphosphoglycerate mutase (BPGM) may contribute to cognitive impairment following ischemic stroke. The $483,480 award will enable the awardee, The General Hospital Corporation (doing business as...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $470,786 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to investigate the role of extracellular mitochondria in driving vascular cognitive impairment after stroke. The project aims to: 1) Elucidate the mechanisms of engulfed...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853), provides $776,503 to The General Hospital Corporation (Massachusetts General Hospital) to investigate the role of perivascular inflammation and vascular remodeling in cerebral small vessel diseases (CSVD), which can lead to intracerebral hemorrhage. The project will leverage autopsy cases and mouse...